Policy | June 02, 2022
PMBI first time ever crossed Rs. 100 crore sales in May, 2022
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
The Da Vinci Robotic-Assisted Surgery system, and Advanced Robotic Surgery Centre was inaugurated early this year
The aim is to provide further insights into patients' lives in the effort to deliver better outcomes for people with psoriatic arthritis (PsA)
The study was conducted in equal laboratory conditions in the Spallanzani Institute in Italy on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus-neutralizing activity (VNA) against Wuhan variant.
This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI)
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Subscribe To Our Newsletter & Stay Updated
